Featured Articles

Biologic Agents for the Treatment of Rheumatoid Arthritis

  Biologic Agents for the Treatment of Rheumatoid Arthritis Maria Victoria Hernandez MD, PhD Medical Director, Rheumatology - Medical Affairs OCTOBER 9, 2018 Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease affecting around 1.5 million people...

Is Marijuana a Replacement for Opioids?

Is Marijuana a Replacement for Opioids? Lynn R. Webster, M.D. Vice President, Scientific Affairs Dr. Webster will be presenting a poster at DIA 2018 in Boston on Tuesday, June 26 on A Phase 1 Pilot Trial to Explore Safety, Pharmacokinetics, and Bioavailability of...

More Posts

Gene Therapy Research and Rare Diseases

  Gene Therapy Research and Rare Diseases   Amy Raymond, PhD, PMP Clinical Strategy Lead - Center for Rare Diseases   Chris Jenkins Principal Partner - Clinical Biosafety Services Join Amy Raymond at World Orphan Drug Congress on Thursday, April 11, 2019, where she'll...

read more

World Rare Disease Day PRA Event

  World Rare Disease Day PRA Event   Derek Ansel Clinical Strategy Lead Center for Rare Disease To show support for Global Genes and rare disease awareness, our Blue Bell colleagues contributed donations and wore denim on Rare Disease Day. PRA Cares matched donations...

read more

Discovering the People Behind the Science: Dr. Aimee Payne

  Discovering the People Behind the Science: Dr. Aimee Payne   Dr. Aimee Payne Associate Professor of Dermatology at the University of Pennsylvania   Derek Ansel Clinical Strategy Lead   Sara Webb Clinical Team Manager JANUARY 28, 2019 Without dedicated scientists, we...

read more

Digital Healthcare Growth Drivers in 2019

  Digital Healthcare Growth Drivers in 2019   Greg Licholai, MD Chief Medical Information Officer JANUARY 9, 2019 The digital transformation of healthcare will see significant growth in the next 12 months fueled by institutional interest in driving down costs and...

read more

Bridging Recruitment Gaps with Academic Collaboration

  Bridging Recruitment Gaps with Academic Collaboration   Dr. Alexandre Malouvier, Scientific Affairs Director, Real World Solutions DECEMBER 5, 2018 As the pharmaceutical industry is rapidly changing, many roles and relationships within it are going through a major...

read more

Winning Team: Working With a Service Dog

  Winning Team: Working With a Service Dog   Billy DeWalt and his wife, Jen Note from Billy: If anyone reading this wants to jump in on the Tobacco Road Marathon, feel free! The course is great for beginners to seasoned runners and is also walker and ruck friendly. If...

read more

Making Clinical Trial Recruitment More Efficient

  Making Clinical Trial Recruitment More Efficient   Larissa Silva, MD Buenos Aires, Argentina   Rebecca Sayers, PhD Raleigh, North Carolina, United States   Jens Dietrich, PhD Berlin, Germany   Russell Brown, PharmD, PhD South Yarra, Victoria, Australia NOVEMBER 26,...

read more

Lung Cancer Awareness Month

  Lung Cancer Awareness Month Stephen Huff Founder of The Huff Project NOVEMBER 6, 2018 Stephen Huff was diagnosed with stage IV inoperable lung cancer at the age of 29. Prior to his diagnosis, Stephen lived an incredibly healthy and clean lifestyle. As a former...

read more

Literature Surveillance: From Abundance to Relevance

  Literature Surveillance: From Abundance to Relevance Andrew Purchase Associate Director of Patient Safety Operations, PV and Patient Safety NOVEMBER 1, 2018 Literature is regarded as a significant source of information in the monitoring of a medicinal product, and...

read more

Updates

Neurodegenerative Research: A Future Mindset

PRA’s William Holt, DO, discusses the critical need for research into Neurodegenerative disorders, with particular emphasis on the future of clinical development and Alzheimer’s Disease research.